American Renal Associates (ARA) Reports Q2 Loss of $0.75

August 9, 2016 5:07 PM EDT
Get Alerts ARA Hot Sheet
Price: $20.45 +0.05%

Today's EPS Names:
Trade ARA Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

American Renal Associates (NYSE: ARA) reported Q2 EPS of ($0.75), versus $0.22 reported last year. Revenue for the quarter came in at $185.6 million versus the consensus estimate of $161.5 million.

Joseph (Joe) Carlucci, Chairman and Chief Executive Officer, said, “We are very pleased to report strong second quarter results. Our first priority is the delivery of high quality patient care, and our organization remains focused on delivering dialysis care in an integrated and coordinated manner with our physician partners. Our second quarter 2016 results demonstrate the continued momentum of our physician partnership model, and the growing acceptance of our differentiated operating philosophy within the nephrology community. We produced net revenue growth of 14.9%, while also continuing to manage our expansion in a disciplined manner.”

“During the second quarter, ARA reached another milestone: we opened our 200th dialysis clinic,” continued Carlucci. “We also added another regional team to support the anticipated growth related to the 35 signed clinics in our pipeline as of June 30, 2016. ARA remains positioned well to execute on this signed pipeline due to high levels of engagement with our physician partners, an experienced team, dedicated caregivers, and a strong management services infrastructure.”

For earnings history and earnings-related data on American Renal Associates (ARA) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Management Comments

Related Entities


Add Your Comment